1. Home
  2. HCM vs VERA Comparison

HCM vs VERA Comparison

Compare HCM & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$13.45

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$26.75

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCM
VERA
Founded
2000
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
HCM
VERA
Price
$13.45
$26.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
14
Target Price
$21.14
★ $71.36
AVG Volume (30 Days)
37.1K
★ 1.3M
Earning Date
07-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.11
N/A
Revenue Next Year
$11.97
$725.78
P/E Ratio
$5.49
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.77
$25.56
52 Week High
$16.33
$56.05

Technical Indicators

Market Signals
Indicator
HCM
VERA
Relative Strength Index (RSI) 40.65 38.28
Support Level $13.00 N/A
Resistance Level $14.74 $36.95
Average True Range (ATR) 0.38 1.62
MACD -0.10 -0.43
Stochastic Oscillator 17.90 18.51

Price Performance

Historical Comparison
HCM
VERA

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: